Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
J Alzheimers Dis. 2022;88(4):1663-1678. doi: 10.3233/JAD-215548.
Consideration of many tests from different cognitive domains in defining mild cognitive impairment (MCI) is clinical routine, but guidelines for a neuropsychological operationalization of MCI are lacking.
Among different operational MCI criteria, to identify those which are best in predicting either conversion to dementia, or a biomarker profile indicative for Alzheimer's disease (AD).
Memory clinic patients without dementia (N = 558; mean age = 66; up to 3 years of follow-up; n = 360 with baseline CSF biomarkers) were included in an observational study using most liberal criteria of cognitive impairment. Four operational definitions of MCI were retrospectively applied: 1) amnestic MCI (CERAD word list delayed recall), 2) CERAD total score, 3) comprehensive criteria and 4) base rate corrected CERAD. We compared their accuracy in predicting incident all-cause dementia or AD dementia within three years, or a concurrent CSF Aβ42/tau-ratio indicative of AD.
The four definitions overlapped considerably, classified 35-58% of the original sample as impaired and were associated with markedly increased PPVs regarding incident all-cause dementia (39-46% versus 26% of the original sample), AD dementia and AD biomarker positivity. The base rate corrected MCI definition had the highest prognostic accuracy.
he operational criteria examined seem suitable to specify MCI in memory clinic settings, as they identify subjects at high risk of clinical progression. Depending on the neuropsychological battery in use, one or several of these criteria could help to calibrate the clinical judgment of test results, reduce false-positive decisions, and define risk-enriched groups for clinical trials.
在定义轻度认知障碍(MCI)时,考虑来自不同认知领域的多项测试是临床常规,但缺乏神经心理学操作 MCI 的指南。
在不同的操作性 MCI 标准中,确定那些最能预测向痴呆转化或具有阿尔茨海默病(AD)生物标志物特征的标准。
无痴呆的记忆诊所患者(N=558;平均年龄 66 岁;最多 3 年的随访;n=360 例有基线 CSF 生物标志物)被纳入一项使用认知障碍最宽松标准的观察性研究。回顾性应用 4 种操作性 MCI 定义:1)遗忘型 MCI(CERAD 单词列表延迟回忆),2)CERAD 总分,3)综合标准和 4)校正基线 CERAD 的基础率。我们比较了它们在预测三年内发生的所有原因痴呆或 AD 痴呆,或同时具有 AD 生物标志物特征的 CSF Aβ42/tau 比值的准确性。
这 4 种定义重叠较大,将原始样本的 35-58%归类为受损,并与显著增加的预测值(39-46%比原始样本的 26%)有关,即所有原因痴呆、AD 痴呆和 AD 生物标志物阳性。校正基线率的 MCI 定义具有最高的预后准确性。
所检查的操作性标准似乎适合在记忆诊所环境中指定 MCI,因为它们确定了具有临床进展高风险的患者。根据使用的神经心理学测试组合,这些标准中的一个或多个标准可以帮助校准测试结果的临床判断,减少假阳性决策,并为临床试验定义风险富集组。